Clinical Trials Logo

Clinical Trial Summary

The aim of the current study is to investigate whether daily intake of Nordic berries for 12 weeks can improve cognitive abilities of adults with mild cognitive impairment, and whether the effect can be linked to changes in metabolic parameters.


Clinical Trial Description

The study will be conducted with a randomized, double-blind, parallel-group (2 arms) placebo-controlled, single-center interventional design. The aim is to investigate the effects on cognitive function and cardiometabolic risk markers after 12 weeks intake of a berry product vs. a reference product. The reference will be isocaloric and matched in taste, appearance, volume and macronutrient composition to the active berry product. Two groups, each of 50 volunteers, are studied. Volunteers will be patients attending the Cognitive medicine unit at Ängelholm hospital, who have mild cognitive impairment (but not dementia). One group of volunteers will consume the berry product while the other group act as control and will consume the reference product. Each volunteer will be seen for a screening visit as well as one pre- and one post-intervention visit at the clinic. In addition, there will be 2 follow-up calls in between visits. Pre- and post-intervention visits will include cognitive assessment with the CANTAB battery (episodic memory and verbal recognition memory), as well as additional cognitive and behavioral tests. Cardiometabolic parameters will be addressed (plasma glucose, insulin, inflammatory markers, blood lipids, body composition) and fecal samples collected. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04317612
Study type Interventional
Source Region Skane
Contact
Status Completed
Phase N/A
Start date June 3, 2020
Completion date February 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03896529 - Neurobiological Mechanisms of Aging and Stress on Prospective Navigation N/A
Terminated NCT02331771 - Donepezil Memory Preservation Post ECT N/A
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT00736034 - The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment Phase 4
Completed NCT04910399 - Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging N/A
Completed NCT02814526 - Exercise in Adults With Mild Memory Problems N/A
Recruiting NCT05289804 - Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment Phase 1/Phase 2
Completed NCT04955457 - BDNF Promoter Methylation: Effects on Cognition, Stress and Anxiety and Depression Symptom in Healthy Women.
Completed NCT05033262 - Our Care Wishes - Dementia N/A
Recruiting NCT01919957 - Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies N/A
Not yet recruiting NCT01708200 - A Comparison of the Effectiveness of Two Types of Memory Training Programs in People With a Diagnosis of Mental Illness. N/A
Recruiting NCT04583215 - Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment N/A
Recruiting NCT05543681 - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's Phase 2
Active, not recruiting NCT03205709 - Cognitive Training and Neuroplasticity in Mild Cognitive Impairment N/A
Recruiting NCT02302482 - Predictive Factors and Autonomy Level Change N/A
Completed NCT02301247 - Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS) N/A
Completed NCT01708304 - Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs) N/A
Recruiting NCT06025877 - Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
Recruiting NCT05122598 - Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease Phase 2
Completed NCT04473235 - Better Memory With Literacy Acquisition Later in Life N/A